4-(6-cyclohexylmethoxy-9H-purin-2-ylamino)-benzamide

**4-(6-cyclohexylmethoxy‑9H‑purin‑2‑ylamino)‑benzamide** is a synthetic small molecule belonging to the hypoxanthine class of purine derivatives. It features a cyclohexylmethoxy group at the O^6 position of the purine ring and an amino-benzamide moiety at the C2 position. The compound has been cataloged in chemical and pharmacological databases as an experimental agent, but there is no evidence it has reached clinical development or approval for any therapeutic indication. Its mechanism of action, biological activity, or specific molecular targets are not described in public drug databases as of June 2025[1][2][4]. No information on its use in humans or animals, nor on its pharmacodynamics or pharmacokinetics, is available.

Other names

4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE4-{[6-(cyclohexylmethoxy)-9H-purin-2-yl]amino}benzamide4-{[6-(cyclohexylmethoxy)-3H-purin-2‑yl]amino}benzamide